ATNM

Actinium Pharmaceuticals, Inc.

Contracts

Total Value

Stock Metrics

2.5%

Short % Float

10.3d to cover · Moderate squeeze

20.5%

Inst % Float

10 holders · 2026-06-30

Vanguard Capital M

Top Holder

4.0% of float

31.0M sh

Public Float

36/100

Dilution Score

Medium

14 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

36/100

MEDIUM

Inst: 20.53% · Top: Vanguard Capital Management LLC

Biotech Analytics

Biotech / Pharma

6.27

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications10

Dilution Risk36

Clinical Trials0

Short Interest10